• Contemporary ClinicContemporary Clinic
  • OTC GuideOTC Guide
  • Pharmacy Times
  • PTCEPTCE
  • Pharmacist Moms GroupPharmacist Moms Group
News
All News
FDA Updates
Press Releases
Media
All Videos
Digital Detail
Independent Corner
Insights
Interviews
MEDcast
Medical World News
Microsites
Peer Exchange
Perfect Consult
Podcasts
Practice Pearls
Sponsored Webcast
Student Voices
Webinars/Webcasts
Conferences
Conference Coverage
Conference Listing
Publications
Pharmacy Times
Pharmacy Practice in Focus: Oncology
Pharmacy Practice in Focus: Health Systems
Pharmacy Careers
All Publications
About the Publications
Author Submission
Submit to Pharmacy Practice in Focus: Oncology
Submit to Pharmacy Practice in Focus: Health Systems
Become a Peer Reviewer
Supplements & Featured Publications
Clinical
503B Compounding Pharmacy
ADHD
Allergy
Alzheimer Disease
Anxiety
Asthma
Atopic Dermatitis
Biosimilars
Bipolar Disorder
Brain Health
Breast Cancer
C. Difficile
COPD
COVID-19
Cardiovascular Health
Cervical Cancer
Cholangiocarcinoma
Cholesterol
Chronic Kidney Disease
Chronic Lymphocytic Leukemia
Classical Hematology
Colorectal Cancer
Continuous Glucose Monitoring
Cough and Cold
Depression
Dermatology
Diabetes
Digestive Health
Dry Eye Disease
Epilepsy
Eye Care
Flu
Future of Pharmacy
Gastrointestinal Cancer
Gastrointestinal Health
Gout
HER2 Breast Cancer
HIV
Heart Failure
Hematology
Hepatitis/MASH
Immunization
Immuno-oncology
Immunoglobulins
Infectious Disease
Lung Cancer
Lymphoma
Macular Degeneration
Mental Health
Migraine
Movement Disorders
Multiple Myeloma
Multiple Sclerosis
Myelofibrosis
Neurology
Neutropenia
Osteoporosis
Ovarian Cancer
Pain Management
Parkinson Disease
Pediatrics
Pharmacy Heroes
Pharmacy Management
Pneumococcal
PrEP
Prostate Cancer
Psoriasis
Psoriatic Arthritis
Psychedelics
Reimbursement
Reproductive Health
Respiratory Syncytial Virus
Rheumatoid Arthritis
Schizophrenia
Shingles
Skin Cancer
Sleep
Travel Vaccines
Veterinary Pharmacy
Vitamins and Supplements
Weight Management
Women's Health
Events
Upcoming Events
Upcoming Webinars
CE
Resources
Clinical Forum
Cou-Co
Educated Patient
Information for the Pharmacist
Interactive Tools
Partners
Sponsored
Whiteboards
Subscribe
logo
Spotlight
Community/RetailHospitalOncologyPharmacy TechnicianStudent
Clinical Role
Community/RetailHospitalOncologyPharmacy TechnicianSpecialty PharmacyStudent
Clinical
CoronavirusBrain HealthCardiovascular HealthDermatologyDiabetesFluHeart FailureHepatitis/MASHImmunizationMigrainePneumococcalVitamins and Supplements
Supplement Spotlight
October 2023 Pharmacy Technician Edition
All News
FDA Updates
Press Releases
All Videos
Digital Detail
Independent Corner
Insights
Interviews
MEDcast
Medical World News
Microsites
Peer Exchange
Perfect Consult
Podcasts
Practice Pearls
Sponsored Webcast
Student Voices
Webinars/Webcasts
Conference Coverage
Conference Listing
Pharmacy Times
Pharmacy Practice in Focus: Oncology
Pharmacy Practice in Focus: Health Systems
Pharmacy Careers
All Publications
About the Publications
Author Submission
Submit to Pharmacy Practice in Focus: Oncology
Submit to Pharmacy Practice in Focus: Health Systems
Become a Peer Reviewer
Supplements & Featured Publications
503B Compounding Pharmacy
ADHD
Allergy
Alzheimer Disease
Anxiety
Asthma
Atopic Dermatitis
Biosimilars
Bipolar Disorder
Brain Health
Breast Cancer
C. Difficile
COPD
COVID-19
Cardiovascular Health
Cervical Cancer
Cholangiocarcinoma
Cholesterol
Chronic Kidney Disease
Chronic Lymphocytic Leukemia
Classical Hematology
Colorectal Cancer
Continuous Glucose Monitoring
Cough and Cold
Depression
Dermatology
Diabetes
Digestive Health
Dry Eye Disease
Epilepsy
Eye Care
Flu
Future of Pharmacy
Gastrointestinal Cancer
Gastrointestinal Health
Gout
HER2 Breast Cancer
HIV
Heart Failure
Hematology
Hepatitis/MASH
Immunization
Immuno-oncology
Immunoglobulins
Infectious Disease
Lung Cancer
Lymphoma
Macular Degeneration
Mental Health
Migraine
Movement Disorders
Multiple Myeloma
Multiple Sclerosis
Myelofibrosis
Neurology
Neutropenia
Osteoporosis
Ovarian Cancer
Pain Management
Parkinson Disease
Pediatrics
Pharmacy Heroes
Pharmacy Management
Pneumococcal
PrEP
Prostate Cancer
Psoriasis
Psoriatic Arthritis
Psychedelics
Reimbursement
Reproductive Health
Respiratory Syncytial Virus
Rheumatoid Arthritis
Schizophrenia
Shingles
Skin Cancer
Sleep
Travel Vaccines
Veterinary Pharmacy
Vitamins and Supplements
Weight Management
Women's Health
Upcoming Events
Upcoming Webinars
CE
Clinical Forum
Cou-Co
Educated Patient
Information for the Pharmacist
Interactive Tools
Partners
Sponsored
Whiteboards
Subscribe
Advertisement

CLINICAL ROLE -

Community/Retail
| Hospital
| Oncology
| Pharmacy Technician
| Student

Article

October 13, 2017

Trending News Today: Trump Signs Sweeping Executive Order on Healthcare

Author(s):

Laurie Toich, Assistant Editor

Top news of the day from across the healthcare landscape.

Yesterday, President Donald Trump issued an executive order that aims to increase low-cost insurance plans, allow employers to help employees to purchase their own insurance, and consolidate the insurance and hospital industries, according to Kaiser Health News. Despite the potential immediate impact, Trump’s order will not affect the upcoming open enrollment period for 2018. The executive order allows numerous government agencies to loosen rules related to association and short-term health plans, which tend to be less costly than more regulated plans, according to Kaiser. Critics report that this may pull healthier Americans out of Affordable Care Act (ACA) plans and result in higher premiums for those who remain in these plans.

Trump also disclosed plans to get rid of subsidies for ACA health plans, which are given to lower-income individuals, according to The New York Times. In addition to the recent executive order, this plan may increase premiums and drive individuals away from more regulated ACA plans. Without subsidies, insurers said they would be forced to increase premiums or have to withdraw from the marketplace, according to the article. The White House said that the government is not authorized to provide subsidies and decided to cut the funding. Previously, both Democrats and Republicans urged the president to continue paying subsidies, the Times reported.

An FDA panel recently endorsed a novel gene therapy for a rare, progressive form of blindness that affects children, according to NPR. After testimonials from physicians, parents of patients, and those helped by the treatment, the panel issued a unanimous recommendation. While the FDA is not required to follow the panel’s recommendation, it typically has in the past. The cost of the novel gene therapy may reach up to $1 million to treat both eyes, but the manufacturer said they would help patients access the drug, according to the article. If approved, the gene therapy would be the first approved treatment for the condition and the first approved gene therapy for the eyes.

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Subscribe Now!
Related Videos
1 expert in this video
1 expert in this video
Austin Texas | Image credit: Kevin Ruck - stock.adobe.com
Pharmacy Times OPC
Related Content
Advertisement
PCAB Accreditation as a Safety Net: GLP-1 Demand and the Spotlight on Compounding Standards
June 27th 2025

PCAB Accreditation as a Safety Net: GLP-1 Demand and the Spotlight on Compounding Standards

Karen Spano, RPh, HDDP
Pharmacy Times, Pharmacy Focus Oncology Edition
June 27th 2025

Allen's Story: The Promising Potential of Intratumoral Immunotherapy

Alexandra Gerlach, Associate Editor
Illustration of immunotherapy attacking multiple myeloma cells | Image Credit: © Noel - stock.adobe.com
June 27th 2025

Is Belantamab Mafodotin Making a Comeback?

Alexandra Gerlach, Associate Editor
Concierge Pharmacy's Role in Cardio-Kidney-Metabolic Health Care
June 17th 2025

Concierge Pharmacy's Role in Cardio-Kidney-Metabolic Health Care

Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPSAQ Cardiology, CACP Aislinn Antrim, Managing Editor
Medical Misinformation Affects Public Understanding of Long COVID
June 27th 2025

Medical Misinformation Affects Public Understanding of Long COVID

Camille Cabas, PharmD
Mantle cell lymphoma -- Image credit: David A Litman | stock.adobe.com
June 27th 2025

New Frontline BTK Inhibitor Strategy Gains FDA Approval in Untreated Mantle Cell Lymphoma

Ami Ali, PharmD, BCOP Mary Dzhuryan, PharmD Candidate Mehrnaz Razavi Vakhshoori, PharmD Candidate
Related Content
Advertisement
PCAB Accreditation as a Safety Net: GLP-1 Demand and the Spotlight on Compounding Standards
June 27th 2025

PCAB Accreditation as a Safety Net: GLP-1 Demand and the Spotlight on Compounding Standards

Karen Spano, RPh, HDDP
Pharmacy Times, Pharmacy Focus Oncology Edition
June 27th 2025

Allen's Story: The Promising Potential of Intratumoral Immunotherapy

Alexandra Gerlach, Associate Editor
Illustration of immunotherapy attacking multiple myeloma cells | Image Credit: © Noel - stock.adobe.com
June 27th 2025

Is Belantamab Mafodotin Making a Comeback?

Alexandra Gerlach, Associate Editor
Concierge Pharmacy's Role in Cardio-Kidney-Metabolic Health Care
June 17th 2025

Concierge Pharmacy's Role in Cardio-Kidney-Metabolic Health Care

Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPSAQ Cardiology, CACP Aislinn Antrim, Managing Editor
Medical Misinformation Affects Public Understanding of Long COVID
June 27th 2025

Medical Misinformation Affects Public Understanding of Long COVID

Camille Cabas, PharmD
Mantle cell lymphoma -- Image credit: David A Litman | stock.adobe.com
June 27th 2025

New Frontline BTK Inhibitor Strategy Gains FDA Approval in Untreated Mantle Cell Lymphoma

Ami Ali, PharmD, BCOP Mary Dzhuryan, PharmD Candidate Mehrnaz Razavi Vakhshoori, PharmD Candidate
Consent Preferences
About Us
Clinical Forums
Advertise
Contact Us
Editorial Staff
Privacy Policy
Terms & Conditions
Do Not Sell My Information
Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences

All rights reserved.